Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Repare Therapeutics Inc. (RPTX) had Stock-Based Compensation of $3.98M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-30.04M |
|
-- |
|
-- |
|
$31.19M |
|
$-31.19M |
|
$1.51M |
|
$-29.67M |
|
$-29.67M |
|
$-30.04M |
|
$-30.04M |
|
$-30.04M |
|
$-30.04M |
|
$-31.19M |
|
$-30.53M |
|
42.59M |
|
42.59M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$140.34M |
|
$1.11M |
|
$3.68M |
|
$144.02M |
|
$18.93M |
|
-- |
|
-- |
|
$18.93M |
|
$125.10M |
|
$125.10M |
|
$125.10M |
|
42.89M |
|
| Cash Flow Statement Financials | |
$-29.13M |
|
$28.79M |
|
$0.08M |
|
$84.72M |
|
$84.45M |
|
$-0.26M |
|
|
Stock-Based Compensation |
$3.98M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.02% |
|
-24.02% |
|
-20.86% |
|
-24.02% |
|
$2.92 |
|
$-0.68 |
|
$-0.68 |
|